Autonomic Control of Insulin Secretion and the Treatment of Heart Failure

Majid, P. A.; Saxton, C.; Dykes, J. R. W.; Galvin, M. C.; Taylor, S. H.
November 1970
British Medical Journal;11/7/1970, Vol. 4 Issue 5731, p328
Academic Journal
No abstract available.


Related Articles

  • Hypotensive sedative effects of insulin in autonomic failure. Mathias, Christopher J.; da Costa, David F.; Fosbraey, Paul; Christensen, Niels Juel; Bannister, Roger // British Medical Journal (Clinical Research Edition);7/18/1987, Vol. 295 Issue 6591, p161 

    Examines the hypotensive and sedative effects of insulin in treating autonomic failure. Rate of blood pressure in patients after insulin administration; Determination of heart rate after hypoglycemia; Standard practice to reverse hypoglycemia.

  • Citations and Clinicians' Notes: Insulin Secretion.  // Current Medical Literature: Diabetes;2003, Vol. 20 Issue 4, p103 

    Presents citations and clinicians' notes on insulin secretion in diabetes. Beneficial effects of insulin on insulin secretion and metabolic control in type 2 diabetic patients; Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes.

  • 502 Beta cell function (insulin secretion) is impaired in patients with stable chronic heart failure. Mammini, C.; Gastaldelli, A.; Passino, C.; Buzzigoli, E.; Agazio, A.; Sironi, A.M.; Ferrannini, E.; Emdin, M. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 3 Issue 1, p129 

    An abstract of the study "Beta cell function (insulin secretion) is impaired in patients with stable chronic heart failure," by C. Mammini and colleagues is presented.

  • Diabetic cardiomyopathy. Acar, Eser; Ural, Dilek; Bildirici, Ulaş; Şahin, Tayfun; Yılmaz, İrem // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Dec2011, Vol. 11 Issue 8, p732 

    Diabetic individuals are at significantly greater risk of developing heart failure (HF) independent from other risk factors such as coronary artery disease (CAD) and hypertension. Diabetic cardiomyopathy (DCP) is defined as ventricular dysfunction in the absence of hypertension, coronary artery...

  • Hypoglykämie und Herzrhythmusstörungen bei Patienten mit Diabetes Typ 2. Hanefeld, M.; Ganz, X.; Nolte, C. // Herz;May2014, Vol. 39 Issue 3, p312 

    Hypoglycemia is a common and potentially life-threatening adverse effect of inappropriate diabetes treatment. Typical cardiac complications are ischemia with angina pectoris, myocardial infarction, stroke and arrhythmias, such as atrial fibrillation (AF), ventricular tachycardia and heart...

  • Heart Rate Variability During Steady-State Exercise in Patients With Heart Failure. Ehrman, Jonathan K.; Kirby, Timothy E.; Leier, Carl V.; Binkley, Philip // Clinical Exercise Physiology;Nov99, Vol. 1 Issue 3, p131 

    Determines the heart rate variability during a steady state exercise in patients with heart failure in Ohio. Differences in autonomic functions and nonautonomic mechanisms; Increase in resting sympathetic tone; Effectiveness of exercise training in the treatment of heart rate variability.

  • Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter. Valensi, P.; Chiheb, S.; Fysekidis, M. // Diabetologia;Jun2013, Vol. 56 Issue 6, p1196 

    Heart rate (HR) predicts cardiovascular morbidity and mortality in individuals either with or without diabetes. In type 2 diabetic patients, cardiac autonomic neuropathy is a risk marker for cardiac morbidity and mortality. A major pathogenic potential may be attributed to vagal depression and...

  • Cardiovascular and neurohormonal responses to i. v. l-arginine in two groups with primary autonomic failure. Kimber, J.; Watson, L.; Mathias, C.J. // Journal of Neurology;Dec2001, Vol. 248 Issue 12, p1036 

    Nitric oxide (NO) is synthesised from the amino-acid l-arginine by the enzyme nitric oxide synthetase (NOS) and modulates a wide variety of neural, cardiovascular and hormonal processes. Cardiovascular autonomic dysfunction and impaired neurohormonal secretion characterise patients with primary...

  • Good Training and Good Luck. Williams, C. Basil // Cortlandt Forum;11/25/2000, Vol. 13 Issue 11, p61 

    Discusses the medical case of a 60-year-old man who has a mild congestive heart failure. Symptoms; Digitalis and insulin treatment; Diagnosis of hemochromatosis.

  • 74 Chronic insulin treatment does not increase the susceptibility to ventricular arrhythmias in rats with acute postinfarction heart failure.  // European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p15 

    An abstract of the study "Chronic insulin treatment does not increase the susceptibility to ventricular arrhythmias in rats with acute postinfarction heart failure," by T. Ramunddal et al, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics